EP Patent

EP2172189A1 — Pharmaceutical Compositions

Assigned to Novartis AG · Expires 2010-04-07 · 16y expired

What this patent protects

A liquid pharmaceutical composition comprising a biodegradable polymer, polyethylene glycol having a molecular weight of less than 600 Daltons, a pharmaceutically active agent and less than 0.5 % of an biologically acceptable organic solvent.

USPTO Abstract

A liquid pharmaceutical composition comprising a biodegradable polymer, polyethylene glycol having a molecular weight of less than 600 Daltons, a pharmaceutically active agent and less than 0.5 % of an biologically acceptable organic solvent.

Drugs covered by this patent

Patent Metadata

Patent number
EP2172189A1
Jurisdiction
EP
Classification
—
Expires
2010-04-07
Drug substance claim
No
Drug product claim
No
Assignee
Novartis AG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.